Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Screening for problematic prescription opioid use.

R C Robinson1, R J Gatchel, P Polatin

  • 1Department of Psychiatry, University of Texas Southwestern Medical Center at Dallas, 75390, USA. Richard.Robinson@UTSouthwestern.edu

The Clinical Journal of Pain
|October 6, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[LED lights in dermatology].

Annales de dermatologie et de venereologie·2017
Same author

Actin-Induced Structure in the Beta-Thymosin Family of Intrinsically Disordered Proteins.

Vitamins and hormones·2016
Same author

Proline isomerisation as a novel regulatory mechanism for p38MAPK activation and functions.

Cell death and differentiation·2016
Same author

Establishing clinically meaningful severity levels for the Tampa Scale for Kinesiophobia (TSK-13).

European journal of pain (London, England)·2015
Same author

Simplified office mycology.

What's new·2014
Same author

Functional restoration for chronic low back pain: Changes in depression, cognitive distortion, and disability.

Journal of occupational rehabilitation·2013

Screening for problematic opioid behavior in chronic pain patients is crucial but challenging. New research aims to identify at-risk individuals for safer opioid management and prevent harmful outcomes.

Area of Science:

  • Pain Medicine
  • Addiction Psychiatry
  • Clinical Pharmacology

Background:

  • The medicinal use of opioids for chronic nonmalignant pain is debated, complicated by their history and societal impact.
  • Traditional definitions of opioid abuse and dependence are ill-suited for patients with chronic pain, necessitating refined assessment criteria.
  • Clinical observations suggest risk factors for opioid misuse exist, yet empirical research on prescreening is limited.

Purpose of the Study:

  • To review areas of controversy and current understanding regarding screening for problematic opioid behavior in chronic nonmalignant pain patients.
  • To highlight the need for improved methods to identify patients at risk for opioid misuse.
  • To emphasize the importance of rigorous research in developing effective prescreening tools.

Main Methods:

Related Experiment Videos

  • Literature review of existing research on opioid use in chronic nonmalignant pain.
  • Analysis of controversies surrounding the definition and identification of problematic opioid behavior.
  • Discussion of the current state and future directions of prescreening methodologies.

Main Results:

  • Prescription of opioids for chronic nonmalignant pain is increasingly accepted, supported by research.
  • Traditional addiction criteria (tolerance, withdrawal) are insufficient for assessing problematic use in this population.
  • A key applicable criterion involves continued opioid use despite negative consequences or lack of pain relief.
  • The field of prescreening for problematic drug behavior is nascent, with limited empirical data.

Conclusions:

  • Refined definitions and screening tools are needed to accurately assess problematic opioid behavior in chronic pain patients.
  • Further rigorous empirical research is essential to develop effective prescreening strategies.
  • Identifying at-risk patients is critical for managing pain effectively while mitigating potential destructive outcomes.